Humacyte HUMA
NASDAQ HUMA
$0.41 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Humacyte (HUMA) Price to Sales (2024 - 2026)

Updated

Humacyte's Price to Sales came in at 102.16 for Q2 2026, down 74.4% from 399.46 a year earlier but up 52.1% from the prior quarter.

Analysis

Humacyte (HUMA) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Humacyte's Price to Sales was 74.50.

  • The five-year range for quarterly Price to Sales is 67.18 (Q1 2026) to 2705.17 (Q3 2024).
  • Business Quant data shows HUMA's Price to Sales at 67.18 (Q1 2026), 74.50 (Q4 2025) and 175.92 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Humacyte 96.51 Mn -101.93 Mn -825,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 102.16
Mar 31, 2026 67.18
Dec 31, 2025 74.50
Sep 30, 2025 175.92
Jun 30, 2025 399.46
Mar 31, 2025 513.06
Sep 30, 2024 2,705.17
Jun 30, 2024 495.99
API Access

Humacyte Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=HUMA&period=max&api_key=YOUR_API_KEY